The future of MRS in toxicology looks promising, with ongoing advancements in technology and methodology. Improvements in spectral resolution and sensitivity, as well as the development of new analytical techniques, will likely expand the range of detectable metabolites and improve the accuracy of MRS studies. Additionally, integrating MRS data with other omics technologies could provide deeper insights into the complex biochemical networks affected by toxins.
